Tenet Closes Upsized Non-Brokered Private Placement to Advance Commercialization of North American Product Offering

Summary

Tenet closed an upsized non-brokered private placement to fund commercialization of its North American product offering. The article lacks specific financial details, drug names, or clinical outcome information.